Monoclonal Antibody Prevented Relapse in Adult-Onset Nephrotic Syndrome

(MedPage Today) — Rituximab (Rituxan) prevented relapse in patients with adult-onset frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS), a randomized trial showed.
Among 66 adults, 87.4% of those treated…